Pharmaceuticals in Germany
Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $40,200.0m in 2019, representing a compound annual growth rate (CAGR) of 0.6% between 2015 and 2019.
- The German government’s decision to increase its focus on the use of generic medicines to reduce healthcare spending and maintain economic stability has resulted in decreasing volumes and a downward pricing pressure on existing drugs.
- The market has been supported to some degree by Germany’s aging population and an increase in age-associated disease, such as diabetes and cardiovascular diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Germany pharmaceuticals market by value in 2019?
- What will be the size of the Germany pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Germany's pharmaceuticals market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent strategic partnerships?
7.6. What threats do leading players face?
8 Company Profiles
8.1. Novartis AG
8.2. F. Hoffmann-La Roche Ltd
8.3. Bayer AG
8.4. Boehringer Ingelheim GmbH
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
List of Tables
Table 1: Germany pharmaceuticals market value: $ billion, 2015-19
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: Germany pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: Germany pharmaceuticals market share: % share, by value, 2019
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Annual Financial Ratios (Continued)
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: F. Hoffmann-La Roche Ltd: key facts
Table 11: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 12: F. Hoffmann-La Roche Ltd: Key Employees
Table 13: Bayer AG: key facts
Table 14: Bayer AG: Annual Financial Ratios
Table 15: Bayer AG: Key Employees
Table 16: Boehringer Ingelheim GmbH: key facts
Table 17: Boehringer Ingelheim GmbH: Key Employees
Table 18: Germany size of population (million), 2015-19
Table 19: Germany gdp (constant 2005 prices, $ billion), 2015-19
Table 20: Germany gdp (current prices, $ billion), 2015-19
Table 21: Germany inflation, 2015-19
Table 22: Germany consumer price index (absolute), 2015-19
Table 23: Germany exchange rate, 2015-19
List of Figures
List of Figures
Figure 1: Germany pharmaceuticals market value: $ billion, 2015-19
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: Germany pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in Germany, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in Germany, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in Germany, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2019
Figure 10: Germany pharmaceuticals market share: % share, by value, 2019
Novartis AG
F. Hoffmann-La Roche Ltd
Bayer AG
Boehringer Ingelheim GmbH
*If Applicable.